Xtant Medical Holdings, Inc.
XTNTUS売上高
$134M
百万USD
営業利益
$7M
百万USD
純利益
$5M
百万USD
ROE
9.8%
最新FY
EPS
$0.03
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $13M | $-0M | $0.00 |
| FY2021 | Q2 | $15M | $-1M | $-0.01 |
| FY2021 | Q3 | $14M | $-2M | $-0.02 |
| FY2021 | FY | $55M | $-5M | $-0.06 |
| FY2022 | Q1 | $13M | $-2M | $-0.03 |
| FY2022 | Q2 | $15M | $-2M | $-0.02 |
| FY2022 | Q3 | $14M | $-2M | $-0.03 |
| FY2022 | FY | $58M | $-8M | $-0.09 |
| FY2023 | Q1 | $18M | $-2M | $-0.02 |
| FY2023 | Q2 | $20M | $-2M | $-0.02 |
| FY2023 | Q3 | $25M | $9M | $0.07 |
| FY2023 | FY | $91M | $1M | $0.01 |
| FY2024 | Q1 | $28M | $-4M | $-0.03 |
| FY2024 | Q2 | $30M | $-4M | $-0.03 |
| FY2024 | Q3 | $28M | $-5M | $-0.04 |
| FY2024 | FY | $117M | $-16M | $-0.12 |
| FY2025 | Q1 | $33M | $0M | $0.00 |
| FY2025 | Q2 | $35M | $4M | $0.02 |
| FY2025 | Q3 | $33M | $1M | $0.01 |
| FY2025 | FY | $134M | $5M | $0.03 |
| FY2026 | Q1 | $21M | $-3M | $-0.02 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $65M | $53M | $55M | $58M | $91M | $117M | $134M |
| 営業利益 | $-8M | $-38M | $-60M | $-2M | $-1M | $-4M | $-7M | $-10M | $-12M | $7M |
| 純利益 | $-19M | $-52M | $-70M | $-8M | $-7M | $-5M | $-8M | $1M | $-16M | $5M |
| 総資産 | $144M | $106M | $46M | $43M | $41M | $55M | $60M | $93M | $94M | $94M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $-7M | $-59M | $-44M | $-44M | $15M | $31M | $34M | $51M | $43M | $51M |
| 営業CF | - | $-1M | $1M | $-0M | $-1M | $0M | $-5M | $-10M | $-12M | $13M |
| EPS | $-1.54 | $-34.76 | $-5.97 | $-0.63 | $-0.25 | $-0.06 | $-0.09 | $0.01 | $-0.12 | $0.03 |
| BPS | $-0.39 | $-4.49 | $-3.33 | $-3.34 | $0.19 | $0.35 | $0.31 | $0.39 | $0.31 | $0.36 |
| ROE | 275.6% | 89.3% | 160.1% | 18.6% | -48.4% | -15.7% | -24.8% | 1.3% | -38.3% | 9.8% |